nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.08	0.25	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.0759	0.237	CbGpPWpGaD
Framycetin—Ototoxicity—Tretinoin—peripheral nervous system neoplasm	0.0475	0.0699	CcSEcCtD
Framycetin—Ototoxicity—Isotretinoin—peripheral nervous system neoplasm	0.0475	0.0699	CcSEcCtD
Framycetin—Ototoxicity—Alitretinoin—peripheral nervous system neoplasm	0.036	0.053	CcSEcCtD
Framycetin—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.0324	0.0478	CcSEcCtD
Framycetin—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.0324	0.0478	CcSEcCtD
Framycetin—Ototoxicity—Cisplatin—peripheral nervous system neoplasm	0.0307	0.0452	CcSEcCtD
Framycetin—Sensitisation—Isotretinoin—peripheral nervous system neoplasm	0.0267	0.0393	CcSEcCtD
Framycetin—Sensitisation—Tretinoin—peripheral nervous system neoplasm	0.0267	0.0393	CcSEcCtD
Framycetin—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.0246	0.0362	CcSEcCtD
Framycetin—Impaired healing—Tretinoin—peripheral nervous system neoplasm	0.0221	0.0325	CcSEcCtD
Framycetin—Impaired healing—Isotretinoin—peripheral nervous system neoplasm	0.0221	0.0325	CcSEcCtD
Framycetin—Impaired healing—Melphalan—peripheral nervous system neoplasm	0.0218	0.032	CcSEcCtD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.0205	0.064	CbGpPWpGaD
Framycetin—Sensitisation—Alitretinoin—peripheral nervous system neoplasm	0.0202	0.0298	CcSEcCtD
Framycetin—Nephrotoxicity—Cisplatin—peripheral nervous system neoplasm	0.0194	0.0285	CcSEcCtD
Framycetin—Impaired healing—Alitretinoin—peripheral nervous system neoplasm	0.0167	0.0246	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.0136	0.0425	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.012	0.0373	CbGpPWpGaD
Framycetin—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.0108	0.0158	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.0107	0.0335	CbGpPWpGaD
Framycetin—Nephropathy toxic—Cisplatin—peripheral nervous system neoplasm	0.0107	0.0158	CcSEcCtD
Framycetin—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.00996	0.0147	CcSEcCtD
Framycetin—Nephropathy toxic—Etoposide—peripheral nervous system neoplasm	0.00982	0.0145	CcSEcCtD
Framycetin—Sensitisation—Epirubicin—peripheral nervous system neoplasm	0.00885	0.013	CcSEcCtD
Framycetin—Sensitisation—Doxorubicin—peripheral nervous system neoplasm	0.00819	0.0121	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00802	0.025	CbGpPWpGaD
Framycetin—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.00785	0.0115	CcSEcCtD
Framycetin—Swelling—Tretinoin—peripheral nervous system neoplasm	0.00785	0.0115	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—AKT1—peripheral nervous system neoplasm	0.00643	0.02	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00628	0.0196	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00611	0.0191	CbGpPWpGaD
Framycetin—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00595	0.00875	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00586	0.0183	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00538	0.0168	CbGpPWpGaD
Framycetin—Swelling—Etoposide—peripheral nervous system neoplasm	0.00464	0.00683	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00453	0.0141	CbGpPWpGaD
Framycetin—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00417	0.00614	CcSEcCtD
Framycetin—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00417	0.00614	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00397	0.0124	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00361	0.0112	CbGpPWpGaD
Framycetin—Viral infection—Epirubicin—peripheral nervous system neoplasm	0.0035	0.00515	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00345	0.0108	CbGpPWpGaD
Framycetin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00343	0.00505	CcSEcCtD
Framycetin—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00341	0.00502	CcSEcCtD
Framycetin—Infection—Topotecan—peripheral nervous system neoplasm	0.00341	0.00502	CcSEcCtD
Framycetin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0034	0.00501	CcSEcCtD
Framycetin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0034	0.00501	CcSEcCtD
Framycetin—Infection—Tretinoin—peripheral nervous system neoplasm	0.00338	0.00498	CcSEcCtD
Framycetin—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00338	0.00498	CcSEcCtD
Framycetin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00336	0.00494	CcSEcCtD
Framycetin—Infection—Melphalan—peripheral nervous system neoplasm	0.00334	0.00491	CcSEcCtD
Framycetin—Viral infection—Doxorubicin—peripheral nervous system neoplasm	0.00324	0.00477	CcSEcCtD
Framycetin—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00316	0.00465	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00314	0.00978	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00301	0.00938	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.00296	0.00922	CbGpPWpGaD
Framycetin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00276	0.00407	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00275	0.00856	CbGpPWpGaD
Framycetin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00269	0.00396	CcSEcCtD
Framycetin—CXCR4—Disease—GNS—peripheral nervous system neoplasm	0.00265	0.00825	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00262	0.00816	CbGpPWpGaD
Framycetin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00258	0.0038	CcSEcCtD
Framycetin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00256	0.00377	CcSEcCtD
Framycetin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00253	0.00372	CcSEcCtD
Framycetin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00369	CcSEcCtD
Framycetin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00369	CcSEcCtD
Framycetin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00248	0.00366	CcSEcCtD
Framycetin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00247	0.00364	CcSEcCtD
Framycetin—Infection—Vincristine—peripheral nervous system neoplasm	0.00247	0.00363	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—peripheral nervous system neoplasm	0.00244	0.0076	CbGpPWpGaD
Framycetin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00243	0.00357	CcSEcCtD
Framycetin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00354	CcSEcCtD
Framycetin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00354	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.0024	0.00749	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00238	0.00741	CbGpPWpGaD
Framycetin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00238	0.0035	CcSEcCtD
Framycetin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00235	0.00345	CcSEcCtD
Framycetin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00233	0.00343	CcSEcCtD
Framycetin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00233	0.00343	CcSEcCtD
Framycetin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0023	0.00338	CcSEcCtD
Framycetin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.0022	0.00323	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00219	0.00684	CbGpPWpGaD
Framycetin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00218	0.00321	CcSEcCtD
Framycetin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00218	0.00321	CcSEcCtD
Framycetin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00318	CcSEcCtD
Framycetin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00318	CcSEcCtD
Framycetin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00214	0.00314	CcSEcCtD
Framycetin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00205	0.00302	CcSEcCtD
Framycetin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00204	0.003	CcSEcCtD
Framycetin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00297	CcSEcCtD
Framycetin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00297	CcSEcCtD
Framycetin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00201	0.00296	CcSEcCtD
Framycetin—Infection—Etoposide—peripheral nervous system neoplasm	0.002	0.00294	CcSEcCtD
Framycetin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00199	0.00294	CcSEcCtD
Framycetin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0019	0.0028	CcSEcCtD
Framycetin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0028	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00185	0.00578	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPP3R1—peripheral nervous system neoplasm	0.00185	0.00577	CbGpPWpGaD
Framycetin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00183	0.00269	CcSEcCtD
Framycetin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00269	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00178	0.00554	CbGpPWpGaD
Framycetin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00177	0.0026	CcSEcCtD
Framycetin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.0026	CcSEcCtD
Framycetin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0017	0.0025	CcSEcCtD
Framycetin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00243	CcSEcCtD
Framycetin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00241	CcSEcCtD
Framycetin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00238	CcSEcCtD
Framycetin—CXCR4—Disease—ENO2—peripheral nervous system neoplasm	0.0016	0.005	CbGpPWpGaD
Framycetin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00158	0.00233	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00155	0.00484	CbGpPWpGaD
Framycetin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00225	CcSEcCtD
Framycetin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00221	CcSEcCtD
Framycetin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00148	0.00218	CcSEcCtD
Framycetin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00148	0.00217	CcSEcCtD
Framycetin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00142	0.0021	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00141	0.0044	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.0014	0.00438	CbGpPWpGaD
Framycetin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0014	0.00206	CcSEcCtD
Framycetin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00203	CcSEcCtD
Framycetin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00138	0.00203	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00136	0.00423	CbGpPWpGaD
Framycetin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00192	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.0013	0.00404	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A1—peripheral nervous system neoplasm	0.00129	0.00403	CbGpPWpGaD
Framycetin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00128	0.00188	CcSEcCtD
Framycetin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00188	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00123	0.00384	CbGpPWpGaD
Framycetin—Nausea—Etoposide—peripheral nervous system neoplasm	0.0012	0.00176	CcSEcCtD
Framycetin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00166	CcSEcCtD
Framycetin—Infection—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00165	CcSEcCtD
Framycetin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00154	CcSEcCtD
Framycetin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00153	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000973	0.00304	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000856	0.00267	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000832	0.0026	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000831	0.00122	CcSEcCtD
Framycetin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000798	0.00117	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000793	0.00247	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000772	0.00114	CcSEcCtD
Framycetin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.00113	CcSEcCtD
Framycetin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.00109	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000728	0.00227	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTPN11—peripheral nervous system neoplasm	0.000722	0.00225	CbGpPWpGaD
Framycetin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000717	0.00106	CcSEcCtD
Framycetin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000714	0.00105	CcSEcCtD
Framycetin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00067	0.000986	CcSEcCtD
Framycetin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000977	CcSEcCtD
Framycetin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00062	0.000913	CcSEcCtD
Framycetin—CXCR4—Disease—ERBB2—peripheral nervous system neoplasm	0.000571	0.00178	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000515	0.00161	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000506	0.00158	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRAS—peripheral nervous system neoplasm	0.000434	0.00135	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—peripheral nervous system neoplasm	0.000405	0.00126	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.0004	0.00125	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000377	0.00117	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000366	0.00114	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000363	0.00113	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000333	0.00104	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—peripheral nervous system neoplasm	0.000318	0.000991	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000304	0.000949	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000283	0.000884	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—peripheral nervous system neoplasm	0.000281	0.000875	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000233	0.000726	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000222	0.000694	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000196	0.000613	CbGpPWpGaD
